We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells Harvesting (PG-APRE1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01088022
Recruitment Status : Unknown
Verified March 2010 by Azienda Ospedaliera di Perugia.
Recruitment status was:  Not yet recruiting
First Posted : March 17, 2010
Last Update Posted : March 17, 2010
Sponsor:
Information provided by:
Azienda Ospedaliera di Perugia

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2013
  Estimated Study Completion Date : April 2013